Our Pipeline

BRC is pioneering the development of cannabinoid therapeutics to deliver innovative medicines to patients with high unmet medical needs. We are advancing a robust pipeline of differentiated medicines designed to address severe and underserved neurological and inflammatory diseases*. Our therapeutics are polymodal and contain major and minor cannabinoids at defined and proprietary ratios.

* Currently under investigator INDs

** Orphan Drug Designation granted